Trump’s Efforts to Bring Pharma Manufacturing Back to the U.S. Hindered by Uncertainty
Navigating Uncertainty in U.S. Pharmaceutical Manufacturing Regulations Recent market analysis indicates a significant cloud of uncertainty surrounding the regulations introduced by former President Donald Trump aimed at enhancing pharmaceutical manufacturing domestically. Despite several executive orders … Read more